CORT vs SPG · P/E 199, rev $421.1M vs rev $3.55B
Corcept Therapeutics Incorporated (CORT) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. SPG currently screens at market cap $0.
Not investment advice. Open the CORT and SPG stock pages for the full models.
Not investment advice.